Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Biological Sciences

2-14-2014

Redox control of human mitochondrial outer membrane protein
mitoneet [2FE-2S] clusters by biological thiols and hydrogen
peroxide
Aaron P. Landry
Louisiana State University

Huangen Ding
Louisiana State University

Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs

Recommended Citation
Landry, A., & Ding, H. (2014). Redox control of human mitochondrial outer membrane protein mitoneet
[2FE-2S] clusters by biological thiols and hydrogen peroxide. Journal of Biological Chemistry, 289 (7),
4307-4315. https://doi.org/10.1074/jbc.M113.542050

This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital
Commons. For more information, please contact ir@lsu.edu.

THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 289, NO. 7, pp. 4307–4315, February 14, 2014
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.

Redox Control of Human Mitochondrial Outer Membrane
Protein MitoNEET [2Fe-2S] Clusters by Biological Thiols and
Hydrogen Peroxide*
Received for publication, December 10, 2013, and in revised form, January 6, 2014 Published, JBC Papers in Press, January 8, 2014, DOI 10.1074/jbc.M113.542050

Aaron P. Landry and Huangen Ding1
From the Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana 70803
Background: MitoNEET is a target of the type II diabetes drug pioglitazone and contains a [2Fe-2S] cluster.
Results: The mitoNEET [2Fe-2S] cluster can be reduced by biological thiols and reversibly oxidized by hydrogen peroxide.
Conclusion: The redox state of mitoNEET [2Fe-2S] clusters can be regulated by thiols and oxidative signals.
Significance: MitoNEET may act as a redox sensor to modulate mitochondrial functions.
The human mitochondrial outer membrane protein mitoNEET
is a novel target of the type II diabetes drug pioglitazone. The
C-terminal cytosolic domain of mitoNEET hosts a redox-active
[2Fe-2S] cluster via an unusual ligand arrangement of three cysteine residues and one histidine residue. Here we report that
human mitoNEET [2Fe-2S] clusters are fully reduced when
expressed in Escherichia coli cells. In vitro studies show that
purified mitoNEET [2Fe-2S] clusters can be partially reduced by
monothiols such as reduced glutathione, L-cysteine or N-acetylL-cysteine and fully reduced by dithiothreitol or the E. coli thioredoxin/thioredoxin reductase system under anaerobic conditions. Importantly, thiol-reduced mitoNEET [2Fe-2S] clusters
can be reversibly oxidized by hydrogen peroxide without disruption of the clusters in vitro and in E. coli cells, indicating that
mitoNEET may act as a sensor of oxidative signals to regulate
mitochondrial functions via its [2Fe-2S] clusters. Furthermore,
the binding of the type II diabetes drug pioglitazone in
mitoNEET effectively inhibits the thiol-mediated reduction of
[2Fe-2S] clusters, suggesting that pioglitazone may modulate
the function of mitoNEET by blocking the thiol-mediated
reduction of [2Fe-2S] clusters in the protein.

The human mitochondrial protein mitoNEET is a novel target of the type II diabetes drugs thiazolidinediones, such as
pioglitazone (1). Genetic studies have shown that the deletion
of mitoNEET in mice results in a reduced oxidative phosphorylation capacity in mitochondria (2). Although an increased
expression of mitoNEET in adipocytes in mice enhances lipid
uptake and storage and inhibits mitochondrial iron transport
into the matrix, depletion of mitoNEET in adipocytes leads to
less weight gain in mice (3), suggesting that mitoNEET may
regulate the energy metabolism in mitochondria (1). Recent
studies further indicated that mitoNEET may have a central
role in neurodegenerative diseases (4, 5) and breast cancer pro-
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liferation (6) by maintaining mitochondrial homeostasis in
cells.
MitoNEET localizes on mitochondrial outer membranes (2)
via the N-terminal transmembrane ␣-helix (residues 14 –32)
(1). Expression of the soluble C-terminal domain (residues
33–108) of mitoNEET in Escherichia coli cells produced a protein that contains a [2Fe-2S] cluster (7). Crystallographic studies revealed that mitoNEET exists as a homodimer, with each
monomer hosting a [2Fe-2S] cluster via an unusual ligand
arrangement of three cysteine residues (Cys-72, Cys-74, and
Cys-83) and one histidine residue (His-87) (8 –10). The [2Fe2S] clusters in mitoNEET are redox-active, with a midpoint
redox potential at pH 7 (Em7) of ⬃0 mV (11, 12). Substitution of
the unique His-87 with cysteine in mitoNEET shifts the Em7
value of the [2Fe-2S] clusters from 0 to ⫺320 mV (11) and
increases the stability of the cluster in the protein (13). The
redox property and stability of the [2Fe-2S] clusters in
mitoNEET are also modulated by the type II diabetes drug
pioglitazone (11), excess zinc (14), resveratrol-3-sulfate (15),
NADPH (16), the interdomain interactions (17, 18), and the
hydrogen bond network in the protein (19), suggesting that
mitoNEET may act as a sensor of multiple signals to regulate mitochondrial functions (19). Interestingly, purified mitoNEET can
also transfer the [2Fe-2S] clusters to apo-protein with a 50% completion time of about 120 min at room temperature (20, 21).
Because mitochondria are the primary sites for iron-sulfur cluster
biogenesis (22), it is appealing to consider that mitoNEET may
participate in the iron-sulfur cluster biogenesis process in human
cells (20, 21). Nevertheless, the iron-sulfur cluster transfer occurs
only when the [2Fe-2S] clusters in mitoNEET are oxidized (20)
and the cluster transfer process is inhibited by NADPH (21), suggesting that the mitoNEET-mediated iron-sulfur cluster transfer
could be regulated by the redox state of the [2Fe-2S] clusters and
by intracellular NADPH.
Because the cytosolic redox potential in eukaryotic cells is
estimated to be around ⫺325 mV (pH 7.0) (23), it is expected
that the mitoNEET [2Fe-2S] clusters (Em7 ⫽ 0 mV) (11, 12)
would be in a reduced state in cells under physiological conditions. Nevertheless, the redox state of the mitoNEET [2Fe-2S]
clusters in cells has not been demonstrated, and specific cellular
components that may reduce the mitoNEET [2Fe-2S] clusters
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have not been identified. Here we report that human
mitoNEET [2Fe-2S] clusters are in the fully reduced state when
expressed in E. coli cells under normal growth conditions and
that purified mitoNEET [2Fe-2S] clusters can be partially
reduced by monothiols such as reduced glutathione, L-cysteine,
and N-acetyl-L-cysteine and fully reduced by dithiothreitol and
the E. coli thioredoxin-1 reduced by thioredoxin reductase and
NADPH. Importantly, the reduced mitoNEET [2Fe-2S] clusters can be reversibly oxidized by hydrogen peroxide without
disruption of the clusters, indicating that the redox state of the
mitoNEET [2Fe-2S] clusters can be modulated by biological
thiols and oxidative signals. Furthermore, we find that the type
II diabetes drug pioglitazone can effectively inhibit the thiolmediated reduction of the mitoNEET [2Fe-2S] clusters in vitro,
suggesting that pioglitazone may modulate the function of
mitoNEET by blocking the thiol-mediated reduction of the
[2Fe-2S] clusters in the protein.

EXPERIMENTAL PROCEDURES
Protein Purification—The gene encoding human mitoNEET33–108
(containing amino acid residues 33–108) was cloned previously
from the human cDNA library as described in Ref. 14. The
mitoNEET mutant in which histidine 87 was substituted with
cysteine (H87C) was constructed using the QuikChange sitedirected mutagenesis kit (Stratagene). The constructed mutation was confirmed by direct sequencing (Operon Co.). Human
mitoNEET and the mitoNEET mutant proteins were prepared
following procedures described previously (14). E. coli thioredoxin-1 (TrxA) and thioredoxin reductase (TrxB) were produced from E. coli cells using the expression vectors pDL59 (24)
and pTrR301 (25), respectively, and purified as described in Ref.
26. Both E. coli thioredoxin and thioredoxin reductase were
purified as the native form. The purity of purified proteins was
greater than 95%, as judged by electrophoresis analysis on a 15%
polyacrylamide gel containing SDS, followed by staining with
Coomassie Blue. The protein concentration of purified
mitoNEET or the mitoNEET mutant H87C was measured at
280 nm using an extinction coefficient of 8.6 mM⫺1cm⫺1. The
protein concentration of thioredoxin-1 and thioredoxin reductase was determined at 280 nm using extinction coefficients of
14.2 and 17.7 mM⫺1cm⫺1, respectively. A Beckman DU640 UVvisible spectrometer equipped with a temperature control was
used for measuring absorption spectra.
Other Chemicals—Pioglitazone, L-cysteine, N-acetyl-L-cysteine, reduced glutathione, and other chemicals were purchased from Sigma. Isopropyl ␤-D-1-thiogalactopyranoside,
NADPH, kanamycin, ampicillin, and dithiothreitol were from
Research Product International Co. Pioglitazone was dissolved
in dimethyl sulfoxide as a stock solution containing 25 mM
pioglitazone. An equal amount of dimethyl sulfoxide was added
to the samples as a control.
EPR Measurements—For whole-cell EPR measurements,
E. coli cells were grown for 2 h before the recombinant protein
expression was induced. After 2 h of protein expression, cells
were harvested, washed once with phosphate buffer (pH 7.5),
and resuspended in phosphate buffer or fresh LB medium. An
aliquot (350 l) of the E. coli cells was then transferred to the
EPR tube and frozen immediately in liquid nitrogen. For the
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FIGURE 1. MitoNEET [2Fe-2S] clusters are fully reduced in E. coli cells. A,
EPR spectra of purified mitoNEET (mito) [2Fe-2S] clusters. Purified mitoNEET
and mitoNEET mutant H87C proteins (20 M [2Fe-2S] clusters) were reduced
with sodium dithionite (dith) (2 mM). Spectrum 1 shows wild-type mitoNEET
[2Fe-2S] clusters. Spectrum 2 shows wild-type mitoNEET [2Fe-2S] clusters
reduced with dithionite. Spectrum 3 shows mitoNEET mutant H87C [2Fe-2S]
clusters. Spectrum 4 shows mitoNEET mutant H87C [2Fe-2S] clusters reduced
with dithionite. mT, millitesla. B, EPR spectra of E. coli cells with or without
recombinant mitoNEET. Recombinant proteins were expressed in E. coli cells
for 2 h at room temperature, and then cells were concentrated to an A600 nm of
15. Spectrum 1 shows E. coli cells containing the expression plasmid pET28b⫹
(pET) only. Spectrum 2 shows E. coli cells expressing wild-type mitoNEET. Spectrum 3 shows E. coli cells expressing the mitoNEET mutant H87C. C, EPR spectra of E. coli cells after reduction with sodium dithionite (2 mM). Spectrum 1
shows E. coli cells containing the expression plasmid pET28b⫹ only. Spectrum
2 shows E. coli cells expressing wild-type mitoNEET. Spectrum 3 shows E. coli
cells expressing the mitoNEET mutant H87C. The results are representative of
three independent experiments.

reduced samples, freshly prepared sodium dithionite was added
to the E. coli cells before the EPR samples were prepared. For
protein sample preparation, purified mitoNEET [2Fe-2S] clusters dissolved in buffer containing 20 mM Tris (pH 8.0) and 500
mM NaCl were purged with pure argon gas in sealed vials for 15
min before reductant was added under anaerobic conditions.
After incubation at 37 °C for 20 min, samples were transferred
to the EPR tubes and frozen immediately in liquid nitrogen. The
X-band EPR spectra were recorded using a Bruker model ESR300 spectrometer equipped with an Oxford Instruments 910
continuous flow cryostat. Routine EPR conditions were as follows: microwave frequency, 9.47 GHz; microwave power, 10.0
milliwatt; modulation frequency, 100 kHz; modulation amplitude, 1.2 millitesla; temperature, 20 K; receive gain, 105.

RESULTS
Human MitoNEET [2Fe-2S] Clusters Expressed in E. coli
Cells Are Fully Reduced—Purified human mitoNEET [2Fe-2S]
clusters are in an oxidized state and have no EPR signals (Fig.
1A). When purified mitoNEET [2Fe-2S]] clusters are reduced
with sodium dithionite (Em7 ⫽ -600 mV (27)), a rhombic EPR
spectrum with gx⫽ 1.895, gy⫽1.937, and gz ⫽ 2.005 appears
(Fig. 1A), as reported previously (7, 19, 28, 29). The gx, gy, and gz
values represent the anisotropic g-factors of a typical [2Fe-2S]
cluster in proteins. In parallel, we also prepared the mitoNEET
mutant H87C, in which the unique ligand His-87 of the [2Fe2S] cluster is replaced with Cys. Although purified mitoNEET
H87C has no EPR signal, addition of sodium dithionite produces a new rhombic EPR spectrum of the [2Fe-2S] cluster,
with gx ⫽ 1.896, gy ⫽ 1.970, and gz ⫽ 1.992, that is distinct from
that of the wild-type mitoNEET (Fig. 1A).
The EPR measurement provides an efficient and non-intrusive approach to determine the redox state of iron-sulfur clusters in proteins in solutions or in whole cells (30, 31). Here, we
VOLUME 289 • NUMBER 7 • FEBRUARY 14, 2014
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took the advantage of EPR to explore the redox state of the
mitoNEET [2Fe-2S] clusters expressed in E. coli cells. Fig. 1B
shows that E. coli cells without any recombinant proteins have
very little or no EPR signals because of low concentrations of
endogenous iron-sulfur proteins in cells (30, 31). Under the
same experimental conditions, E. coli cells expressing human
mitoNEET show a rhombic EPR signal at g ⫽ 1.94, which is
identical to that of the reduced mitoNEET [2Fe-2S] clusters
(Fig. 1A). In contrast, E. coli cells expressing the mitoNEET
mutant H87C do not have any EPR signals (Fig. 1B), although both
mitoNEET and the mitoNEET mutant H87C are expressed similarly in E. coli cells on the basis of SDS-PAGE gel analysis (data not
shown). This is likely because the mutation of His-87 to Cys shifts
the Em7 value of the mitoNEET [2Fe-2S] clusters from 0 to ⫺320
mV (11). Because the cytosolic redox potential of E. coli cells is
about ⫺260 mV (32), the mitoNEET mutant H87C [2Fe-2S]
clusters would be mostly in an oxidized (EPR-silent) state in
E. coli cells.
To further examine the redox state of the [2Fe-2S] clusters
in wild-type mitoNEET and the mitoNEET mutant H87C
expressed in E. coli cells, excess sodium dithionite is added to
the cells to reduce all iron-sulfur proteins. Fig. 1C shows that
addition of sodium dithionite to E. coli cells without recombinant proteins does not produce any new EPR signals. On
the other hand, addition of sodium dithionite to E. coli cells
expressing the mitoNEET mutant H87C generates an EPR signal at g ⫽ 1.97, which is the same as that of the reduced
mitoNEET mutant H87C [2Fe-2S] clusters (Fig. 1A). Thus, the
oxidized [2Fe-2S] clusters in the mitoNEET mutant H87C in
E. coli cells can be reduced by sodium dithionite. In contrast,
the EPR signal at g ⫽ 1.94 of the E. coli cells expressing the
wild-type mitoNEET is not changed by addition of sodium
dithionite, suggesting that the wild-type mitoNEET [2Fe-2S]
clusters are fully reduced in E. coli cells even before the addition
of sodium dithionite. Because the cytosolic redox potential in
eukaryotic cells (-325 mV (23)) is about 65 mV lower than that
in E. coli cells (-260 mV (32)), we postulate that the mitoNEET
[2Fe-2S] clusters are most likely in a reduced state in human
cells under physiological conditions.
Human MitoNEET [2Fe-2S] Clusters Can Be Reduced by Biological Thiols—Although it has been shown that the mitoNEET
[2Fe-2S] clusters are redox-active (11, 12), specific biological
molecules that can reduce or oxidize the mitoNEET [2Fe-2S]
clusters are unknown. Because the mitoNEET [2Fe-2S] clusters
are fully reduced in E. coli cells, we reason that the mitoNEET
[2Fe-2S] clusters may be reduced by cellular reducing components that are common in both human and E. coli cells. However, NADPH is not one of them because NADPH fails to
reduce the mitoNEET [2Fe-2S] clusters in vitro (21). Among
other cellular reducing components, biological thiols are abundant. More importantly, biological thiols are able to form relatively stable intermediate thiol free radicals (33, 34) that can
potentially provide electrons for the single-electron reduction
of the oxidized [2Fe-2S] clusters in mitoNEET.
To test this idea, purified mitoNEET was incubated with thiols under anaerobic conditions. After incubation, the samples
were subjected to EPR and UV-visible absorption measurements.
The reduced mitoNEET [2Fe-2S] clusters were observed from the
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FIGURE 2. MitoNEET [2Fe-2S] clusters can be reduced by biological thiols
in vitro. A, EPR spectra of the mitoNEET [2Fe-2S] clusters after reduction with
different thiols. Purified mitoNEET [2Fe-2S] clusters (14 M) (spectrum 1) were
incubated with 2 mM of GSH (spectrum 2), L-cysteine (L-Cys) (spectrum 3),
N-acetyl-L-cysteine (NAC) (spectrum 4), or DTT (dith) (spectrum 5) at 37 °C for 20
min under anaerobic conditions. The EPR spectrum of fully reduced mitoNEET
[2Fe-2S] clusters (spectrum 6) was obtained by adding sodium dithionite (2
mM). mT, millitesla. B, UV-visible spectra of mitoNEET [2Fe-2S] clusters after
incubation with biological thiols. Purified mitoNEET [2Fe-2S] clusters (14 M)
(spectrum 1) was incubated with 2 mM of GSH (spectrum 2), L-cysteine (spectrum 3), N-acetyl-L-cysteine (spectrum 4), or DTT (spectrum 5) at 37 °C for 20
min under anaerobic conditions. The absorption peaks at 455 nm and 550 nm
represent the oxidized mitoNEET [2Fe-2S] clusters, and the new absorption
peak at 420 nm represents the reduced mitoNEET [2Fe-2S] clusters.

EPR signal at g ⫽ 1.94, and the UV-visible absorption peaks at 420
and 550 nm. As shown in Fig. 2, all biological thiols tested (reduced
glutathione, L-cysteine, and N-acetyl-L-cysteine) are able to
partially reduce the mitoNEET [2Fe-2S] clusters. Reduced glutathione appears to have the least ability to reduce the
mitoNEET [2Fe-2S] clusters. L-cysteine and N-acetyl-L-cysteine are able to reduce about 50% of the mitoNEET [2Fe-2S]
clusters in solution under anaerobic conditions, in comparison
with the fully reduced mitoNEET [2Fe-2S] clusters by sodium
dithionite. A further increase of L-cysteine concentration (up to
50-fold excess over the mitoNEET [2Fe-2S] clusters) or incubation time (up to 60 min) does not increase the amount of the
reduced mitoNEET [2Fe-2S] clusters in the incubation solution
(data not shown), suggesting that L-cysteine could not fully
reduce the mitoNEET [2Fe-2S] clusters under the experimental
conditions. Interestingly, incubation with dithiothreitol, a
dithiol that has an Em7 value of ⫺323 mV (35), almost fully
reduced the mitoNEET [2Fe-2S] clusters under the same experimental conditions (Fig. 2).
Human MitoNEET [2Fe-2S] Clusters Can Be Fully Reduced
by the E. coli Thioredoxin/Thioredoxin Reductase System—The
biological equivalent of dithiothreitol is the ubiquitous thioredoxin (36). The Em7 value of E. coli thioredoxin-1 is about ⫺270
mV (37), which is close to that of dithiothreitol (35). To test
whether the oxidized mitoNEET [2Fe-2S] clusters can be
reduced by thioredoxin-1, we prepared E. coli thioredoxin-1
and thioredoxin reductase as described previously (26). When
purified mitoNEET [2Fe-2S] clusters are incubated with
equimolar concentrations of the E. coli thioredoxin/thioredoxin reductase or an excess amount of NADPH under anaerJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 3. Reduction of mitoNEET [2Fe-2S] clusters by the thioredoxin
reductase system in vitro. Purified mitoNEET (mito) [2Fe-2S] clusters (10 M)
(spectrum 1) were incubated with NADPH (500 M) (spectrum 2); E. coli thioredoxin (TrxA, 10 M) and thioredoxin reductase (TrxB, 10 M) (spectrum 3); or
E. coli thioredoxin (10 M), thioredoxin reductase (10 M), and NADPH (500
M) (spectrum 4) at 37 °C for 20 min under anaerobic conditions. Spectrum 5
shows purified mitoNEET [2Fe-2S] clusters reduced with dithiothreitol (2 mM).
Spectrum 6 shows the mitoNEET mutant H87C [2Fe-2S] clusters (10 M) incubated with E. coli thioredoxin-1 (10 M), thioredoxin reductase (10 M), and
NADPH (500 M) at 37 °C for 20 min under anaerobic conditions. After incubation, the samples were transferred to EPR tubes for EPR measurements. The
results are representative of three independent experiments. mT, millitesla.

obic conditions, the mitoNEET [2Fe-2S] clusters remained in
an oxidized state (Fig. 3). This could be because purified thioredoxin-1 is mostly oxidized during the protein purification process. Indeed, when purified mitoNEET [2Fe-2S] clusters were
incubated with thioredoxin-1 prereduced with thioredoxin
reductase and NADPH, the mitoNEET [2Fe-2S] clusters were
fully reduced (Fig. 3). On the other hand, the mitoNEET mutant
H87C [2Fe-2S] clusters that have an Em7 of ⫺320 mV (11) cannot be reduced by the E. coli thioredoxin/thioredoxin reductase
system under the same experimental conditions (Fig. 3). This is
consistent with the observation that the mitoNEET mutant
H87C [2Fe-2S] clusters are in an oxidized state when expressed
in E. coli cells (Fig. 1B). Taken together, the results suggest
that the wild-type mitoNEET [2Fe-2S] clusters can be fully
reduced by the E. coli thioredoxin/thioredoxin reductase
system in vitro.
Reduced mitoNEET [2Fe-2S] Clusters Can Be Reversibly Oxidized by Hydrogen Peroxide—Previous studies have shown that
iron-sulfur clusters in regulatory proteins can undergo redox
transition in response to oxidative signals without disruption of
the clusters (38 – 41). To explore whether the mitoNEET [2Fe2S] clusters may also act as a redox sensor to oxidative signals,
we examined the stability of the mitoNEET [2Fe-2S] clusters
under oxidative stress conditions. Fig. 4A shows that, when
purified mitoNEET [2Fe-2S] clusters were incubated with
increasing concentrations of hydrogen peroxide (up to 50-fold
excess), the UV-visible absorption spectrum of the mitoNEET
[2Fe-2S] clusters remains essentially unchanged, indicating
that the mitoNEET [2Fe-2S] clusters are stable in the presence
of hydrogen peroxide.
We then asked whether the prereduced mitoNEET [2Fe-2S]
clusters can be oxidized by hydrogen peroxide. To avoid possible effects of NADPH on the stability of the mitoNEET [2Fe-2S]
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clusters (16), we prereduced the mitoNEET [2Fe-2S] clusters
with excess dithiothreitol under anaerobic conditions. As
shown in Fig. 4B, the prereduced mitoNEET [2Fe-2S] clusters
were quickly oxidized upon addition of hydrogen peroxide.
Further incubation with dithiothreitol after hydrogen peroxide
treatment led to a full rereduction of the oxidized mitoNEET
[2Fe-2S] clusters within about 14 min (Fig. 4, B and C). The EPR
measurements of the protein samples taken from the reaction
solution further confirm that the amount of the mitoNEET
[2Fe-2S] clusters remain the same before and after hydrogen
peroxide treatment (Fig. 4D), suggesting that the mitoNEET
[2Fe-2S] clusters can undergo redox transition in response to
hydrogen peroxide without disruption of the cluster.
To further explore whether the mitoNEET [2Fe-2S] clusters
could undergo redox transition in vivo in response to hydrogen
peroxide, E. coli cells expressing mitoNEET [2Fe-2S] clusters
are treated with hydrogen peroxide. As shown in Fig. 5, addition
of hydrogen peroxide (1 mM) to the E. coli cells largely eliminates the EPR signal at g ⫽ 1.94 of the reduced mitoNEET
[2Fe-2S] clusters. Reincubation of the E. coli cells in LB medium
after hydrogen peroxide treatment quickly restores the EPR
signal at g ⫽ 1.94 of the reduced mitoNEET [2Fe-2S] clusters,
demonstrating that the mitoNEET [2Fe-2S] clusters can
undergo redox transition in response to hydrogen peroxide in
E. coli cells.
The Type II Diabetes Drug Pioglitazone Inhibits the Thiolmediated Reduction of the mitoNEET [2Fe-2S] Clusters—It has
been reported that binding of the type II diabetes drug pioglitazone shifts the Em7 value of the mitoNEET [2Fe-2S] clusters
by ⫺100 mV (11). The negative shift of the Em7 value would
make it more difficult to reduce the mitoNEET [2Fe-2S] clusters. Nevertheless, how the redox state of the mitoNEET [2Fe2S] clusters may be modulated by pioglitazone is unknown.
With the finding that the mitoNEET [2Fe-2S] clusters can be
reduced by biological thiols, we sought to investigate the
effect of pioglitazone on the thiol-mediated reduction of the
mitoNEET [2Fe-2S] clusters. Purified mitoNEET is preincubated with pioglitazone, followed by reduction with thiols
under anaerobic conditions. Fig. 6A shows that binding of
pioglitazone had little or no effect on the dithionite-mediated
reduction of the mitoNEET [2Fe-2S] clusters because dithionite is
a strong reductant (Em7 ⫽ ⫺660 mV (27)). On the other hand,
binding of pioglitazone largely inhibits the dithiothreitol-mediated reduction of the mitoNEET [2Fe-2S] clusters (Fig. 6B). Titration experiments showed that, as the concentration of pioglitazone increased gradually in the incubation solutions (from 0 to 2.5
mM), the amount of the dithiothreitol-reduced mitoNEET [2Fe2S] clusters was decreased progressively (Fig. 6C). We also tested
whether pioglitazone affected the thioredoxin-mediated reduction of the mitoNEET [2Fe-2S] clusters in vitro. As shown in
Fig. 6D, binding of pioglitazone greatly inhibited the thioredoxin-mediated reduction of the mitoNEET [2Fe-2S] clusters,
suggesting that pioglitazone can effectively block the biological
thiol-mediated reduction of the mitoNEET [2Fe-2S] clusters in
cells. Nevertheless, attempts to modulate the redox state of the
mitoNEET [2Fe-2S] clusters expressed in E. coli cells with
pioglitazone were not successful. This is likely because pioglitazone may not easily penetrate bacterial cell walls and/or cell
VOLUME 289 • NUMBER 7 • FEBRUARY 14, 2014
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membranes because addition of pioglitazone to the cell extracts
prepared from E. coli cells effectively inhibits the thiol-mediated reduction of the mitoNEET [2Fe-2S] clusters in the cell
extracts (data not shown).

DISCUSSION
In this study, we report that human mitoNEET [2Fe-2S] clusters are fully reduced when expressed in E. coli cells under normal growth conditions and that the mitoNEET [2Fe-2S] clusters can be partially reduced by monothiols and fully reduced by
dithiothreitol and the E. coli thioredoxin-1 reduced by thioredoxin reductase and NADPH in vitro. Importantly, the thiolreduced mitoNEET [2Fe-2S] clusters can be reversibly oxidized
by hydrogen peroxide without disruption of the clusters. Furthermore, binding of the type II diabetes drug pioglitazone effectively
blocks the thiol-mediated reduction of the mitoNEET [2Fe-2S]
clusters. The results suggest that the mitoNEET [2Fe-2S] cluster
may act as a sensor of oxidative signals to regulate mitochondrial
function and that the type II diabetes drug pioglitazone may modulate the function of mitoNEET by blocking the thiol-mediated
FEBRUARY 14, 2014 • VOLUME 289 • NUMBER 7

reduction of the [2Fe-2S] clusters in cells. The possible interplay
among biological thiols, hydrogen peroxide, and the type II diabetes drug pioglitazone in regulating the redox state of the
mitoNEET [2Fe-2S] clusters is shown in Fig. 7.
The interaction between thioredoxin and iron-sulfur clusters
in proteins has been well established in ferredoxin-thioredoxin
reductase, where the reduced iron-sulfur clusters provide electrons for reduction of the oxidized thioredoxin (42, 43). However, to the best of our knowledge, the reduction of iron-sulfur
clusters in proteins by biological thiols has not been reported
previously. The unique ligand arrangement (Cys-72, Cys-74,
Cys-83, and His-87) (8 –10) and relatively high Em7 value (0
mV) (11, 12) may facilitate the reduction of the mitoNEET
[2Fe-2S] clusters by biological thiols because a single mutation
(His-87 to Cys) in mitoNEET shifts the Em7 value of the [2Fe2S] clusters from 0 to ⫺320 mV (11) and effectively prevents the
reduction of the clusters by biological thiols (Fig. 3). Unlike
NADPH, which fails to reduce the mitoNEET [2Fe-2S] clusters
in vitro (21), biological thiols have a relatively stable intermediate state of thiol free radical (33, 34) that can provide electrons
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for the single-electron reduction of the [2Fe-2S] clusters in
mitoNEET. Interestingly, monothiols, such as reduced glutathione, L-cysteine, and N-acetyl-L-cysteine, can only partially
reduce the mitoNEET [2Fe-2S] clusters, even at high concentrations and with extended incubation time. On the other hand,
dithiothreitol (Fig. 2) and E. coli thioredoxin prereduced with
thioredoxin reductase and NADPH (Fig. 3) can fully reduce the
mitoNEET [2Fe-2S] clusters. The redox reactions underlying
the reduction of the mitoNEET [2Fe-2S] clusters by biological
thiols remain to be further investigated. Nevertheless, the finding that the reduced thioredoxin can reduce the mitoNEET
[2Fe-2S] clusters is highly significant. Thioredoxin is highly
conserved from bacteria to humans (36). In human cells, there
are two major thioredoxins: thioredoxin-1, which is located in
the cytosol and nucleus, and thioredoxin 2, which is located in
mitochondria (44). The Em7 value of human cytosolic thioredoxin-1 is about ⫺230 mV (pH 7.0) (45), which is close to that
of E. coli thioredoxin-1 (-270 mV) (37). Therefore, human thioredoxin-1 could be responsible for reducing the mitoNEET
[2Fe-2S] clusters. Because human thioredoxin 1 has an essential
role in the regulation of complex diseases, including cancer
(46), cardiovascular disease, type II diabetes, and aging (47),
the proposed role of human thioredoxin-1 in reducing the
mitoNEET [2Fe-2S] clusters may provide fresh clues for the
links between thioredoxin and various human diseases. However, it should be pointed out that other biological thiols, such
as glutathione, L-cysteine, and glutaredoxins (48), may also
reduce the mitoNEET [2Fe-2S] clusters in cells.
As a novel target of the type II diabetes drug pioglitazone,
mitoNEET has a specific interaction with pioglitazone (1). It
has been speculated that pioglitazone may modulate the energy
metabolism in mitochondria via direct interaction with
mitoNEET (49). Previous studies indicated that binding of
pioglitazone stabilizes the [2Fe-2S] clusters in mitoNEET (10)
and shifts the Em7 value of the [2Fe-2S] clusters from 0 to ⫺100
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mV (11). Here, we find that binding of pioglitazone effectively
inhibits the thiol-mediated reduction of the mitoNEET [2Fe2S] clusters, likely because of the decreased Em7 value of the
[2Fe-2S] clusters in the protein. Thus, pioglitazone may alter
the function of mitoNEET by blocking the thiol-mediated
reduction of the [2Fe-2S] clusters in cells. A set of novel ligands
have been identified recently that may target mitochondrial
mitoNEET (50, 51). It would be of interest to explore the effect
of these ligands on the thiol-mediated reduction of the
mitoNEET [2Fe-2S] clusters.
The finding that the mitoNEET [2Fe-2S] clusters can be
reversibly oxidized by hydrogen peroxide without disruption of
the clusters strongly suggests that the mitoNEET [2Fe-2S] cluster may act as a redox sensor to oxidative signals. The redox
state of the [2Fe-2S] clusters in mitoNEET has already been
attributed to regulating the iron-sulfur cluster transfer from
mitoNEET to target proteins (20, 21). It would also be possible
that the redox state of the [2Fe-2S] clusters may directly modulate the energy metabolism in mitochondria via specific proteinVOLUME 289 • NUMBER 7 • FEBRUARY 14, 2014
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FIGURE 7. Proposed model for redox regulation of mitoNEET [2Fe-2S] clusters in response to biological thiols, hydrogen peroxide, and the type II
diabetes drug pioglitazone. Two thiols reduce two mitoNEET [2Fe-2S] clusters via the single-electron reduction process to produce two thiol free radicals that
may form a disulfide. Reduced [2Fe-2S] clusters in mitoNEET are reversibly oxidized by hydrogen peroxide. Binding of the type II diabetes drug pioglitazone to
mitoNEET shifts the Em7 value of the [2Fe-2S] clusters by ⫺100 mV and blocks the thiol-mediated reduction of the clusters in the protein.

protein interactions between mitoNEET and mitochondrial proteins, such as pyruvate dehydrogenase, in mitochondria (49). In
crystal structural models, mitoNEET exists as a homodimer with
two mitoNEET monomers tightly associated via the “␤ cap” structure (8 –10). The closest distance between the two [2Fe-2S] clusters in the mitoNEET dimer is about 14 Å. We envision that,
when the reduced [2Fe-2S] clusters are oxidized, two positive
charges are introduced to the mitoNEET dimer. The electrostatic repulsion between the two [2Fe-2S] clusters in the
mitoNEET dimer could lead to subtle conformation change
and, consequently, modulate mitochondrial functions. A similar redox regulation of iron-sulfur clusters has been proposed
for a number of proteins (40). For example, in the redox transcription factor SoxR, oxidation of the [2Fe-2S] clusters
switches on its transcription activity (38, 41). In the bacterial
DNA damage-inducible DNA helicase DinG, the enzyme is
active only when the reduced [4Fe-4S] cluster is oxidized (39).
In this context, we propose that mitoNEET may represent a
new member of this redox signaling protein family in human
cells.
A genome-wide search revealed that humans have at least
two mitoNEET related proteins, Miner1 (52) and Miner2 (2),
that share the conserved CDGSH domain with mitoNEET (53).
Miner1 was initially localized in the endoplasmic reticulum
(54), but a recent study indicated that Miner1 is mostly associated with the mitochondrial outer membrane (55). Mutations
in the Miner1 gene have been attributed to Wolfram syndrome 2,
a disease characterized by juvenile-onset diabetes mellitus and
optic atrophy (54). Biochemical studies have shown that Miner1
interacts with BCL2 (B-cell lymphoma 2) (56) and regulates the
sulfhydryl redox status, the unfolded protein response, and Ca2⫹
homeostasis in mitochondria via an unknown mechanism (57).
Like mitoNEET, Miner1 hosts a [2Fe-2S] cluster via an unusual
three cysteine residues and one histidine residue in its C-terminal domain (52). Although the function of Miner2 remains
unknown, Miner2 is also located on the mitochondrial outer
membrane and, most likely, contains a [2Fe-2S] cluster hosted
by three cysteine residues and one histidine residue (2). The
existence of [2Fe-2S] clusters in mitoNEET (7), Miner1 (52),
and, most likely, in Miner2 (2) strongly suggests that the [2Fe2S] clusters in this group of mitochondrial outer membrane
proteins (53) may share similar and crucial regulatory functions. If the [2Fe-2S] clusters in Miner1 and Miner2, like that in
mitoNEET, can be reduced by biological thiols and reversibly
oxidized by hydrogen peroxide, Miner1 and Miner2 may also
act as redox sensors to modulate specific functions in response
to oxidative signals in human cells.
FEBRUARY 14, 2014 • VOLUME 289 • NUMBER 7
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